Joseph Lasaga
Corporate Officer/Principal bei RIGEL PHARMACEUTICALS, INC.
Profil
Joseph Lasaga is a Senior Vice President-Corporate Development at Rigel Pharmaceuticals, Inc. He previously worked as a Senior Director-Business Development at Nektar Therapeutics from 2010 to 2014 and as a VP-Business Development & Alliance Management at Galena Biopharma, Inc. from 2014 to 2016.
Joseph holds an MBA from San Francisco State University and an undergraduate degree from San Jose State University.
Aktive Positionen von Joseph Lasaga
Unternehmen | Position | Beginn |
---|---|---|
RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.1998 |
Ehemalige bekannte Positionen von Joseph Lasaga
Unternehmen | Position | Ende |
---|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Corporate Officer/Principal | 01.10.2016 |
NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01.08.2014 |
Ausbildung von Joseph Lasaga
San Francisco State University | Masters Business Admin |
San Jose State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |